88 CHAPTER 4 26 van de Stadt LA, van der Horst AR, de Koning MH, Bos WH, Wolbink GJ, van de Stadt RJ, Pruijn GJ, Dijkmans BA, van Schaardenburg D, Hamann D. 2011; The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia. Ann Rheum Dis. 70(1):128–33. 27 de Hair MD, Landewé R, van de Sande MVD, van Schaardenburg D, van Baarsen L V, Gerlag D, Tak P. 2013; Smoking and overweight determine the likelihood of developing rheumatoid arthritis. Ann Rheum Dis. 72:1654–8. 28 Hemminki K, Li X, Sundquist J, Sundquist K. 2009; Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions. Arthritis Rheum. 60(3):661– 8. 29 Wellcome Trust Case Control C. 2007; Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 447(7145):661–78. 30 van der Helm-van Mil AH, Huizinga TW, Schreuder GM, Breedveld FC, de Vries RR, Toes RE. 2005; An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility. Arthritis Rheum. 52(9):2637–44. 31 Silman AJ, Newman J, MacGregor AJ. 1996; Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins. Arthritis Rheum. 39(5):732–5. 32 Liu X, Tedeschi SK, Barbhaiya M, Leatherwood CL, Speyer CB, Lu B, Costenbader KH, Karlson EW, Sparks JA. 2019; Impact and Timing of Smoking Cessation on Reducing Risk of Rheumatoid Arthritis Among Women in the Nurses’ Health Studies. Arthritis Care Res (Hoboken). 71(7):914–24. 33 Lahiri M, Luben RN, Morgan C, Bunn DK, Marshall T, Lunt M, Verstappen SM, Symmons DP, Khaw KT, Wareham N, Bruce IN. 2014; Using lifestyle factors to identify individuals at higher risk of inflammatory polyarthritis (results from the European Prospective Investigation of Cancer-Norfolk and the Norfolk Arthritis Register–the EPIC-2-NOAR Study). Ann Rheum Dis. 73(1):219–26. 34 Hu Y, Sparks JA, Malspeis S, Costenbader KH, Hu FB, Karlson EW, Lu B. 2017; Longterm dietary quality and risk of developing rheumatoid arthritis in women. Ann Rheum Dis. 76(8):1357–64. 35 Di Giuseppe D, Bottai M, Askling J, Wolk A. 2015; Physical activity and risk of rheumatoid arthritis in women: a population-based prospective study. Arthritis Res Ther. 17:40. 36 Song H, Fang F, Tomasson G, Arnberg FK, Mataix-Cols D, de la Cruz L, Almqvist C, Fall K, Valdimarsdottir UA. 2018; Association of Stress-Related Disorders With Subsequent Autoimmune Disease. JAMA. 319(23):2388–400. 37 van de Stadt LA, Witte BI, Bos WH, van Schaardenburg D. 2013; A prediction rule for the development of arthritis in seropositive arthralgia patients. Ann Rheum Dis. 72(12):1920–6. 38 Hilliquin S, Hugues B, Mitrovic S, Gossec L, Fautrel B. 2018; Ability of disease-modifying antirheumatic drugs to prevent or delay rheumatoid arthritis onset: a systematic literature review and meta-analysis. Ann Rheum Dis. 77:1099–106. 39 Higgins JPT Thomas J CJCMLTPMJWVA (editors). 2022. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). [Internet]. Cochrane; 40 2015. Trial registration: Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis (StopRA) [Internet].
RkJQdWJsaXNoZXIy MTk4NDMw